Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

INTERIM MANAGEMENT STATEMENT

15 May 2025 11:44

RNS Number : 8566I
Mandarin Oriental International Ltd
15 May 2025
Β 

ANNOUNCEMENT

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

15 May 2025 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2025.

Β 

Laurent Kleitman, Group Chief Executive, said:

"Clear vision, strategy, and sharpened focus have enabled early wins this year with solid growth in RevPAR and market share globally. We have strategically expanded our global footprint - most notably with the addition of the iconic Mandarin Oriental Lutetia, Paris, to our portfolio. Concurrently, we continue to elevate the brand through significant investments in our founding flagship hotels in Hong Kong and Bangkok, reinforcing our commitment to delivering exceptional, brand-led, guest-centric experiences. We remain focused on driving long-term value creation for the Group as we execute our growth

strategy."

Β 

In Q1, the Group reported higher Revenue per Available Room ('RevPAR') in all regions compared to the prior year. The Management Business drove higher hotel management fee income from strong hotel RevPARs and continued to invest in the capability to enable the Group to execute against its long-term growth strategy. Owned Hotels, particularly in Hong Kong, generated higher profitability than the prior year, offsetting the absence of earnings from Paris following the disposal of that hotel property in 2024. Overall, the Group's underlying profit in the quarter was higher than last year.

Β 

The Group has also made excellent progress in accelerating the growth of its portfolio. In the first quarter, two new hotel and residences management agreements were announced: a resort with residences in Puerto Rico, offering an immersive experience at Esencia in BoquerΓ³n Bay, and a luxury hotel in Suzhou, China, featuring panoramic views of the renowned Jinji Lake. In April, the Group strengthened its European presence with the opening of its second property in Paris - Mandarin Oriental Lutetia, Paris. The Group also took over the management of The Conservatorium Hotel, its first flag in Amsterdam, and targets to complete the rebranding of this property in 2026.

Β 

Reaffirming our commitment to delivering brand-led, guest-centric experiences, in April, the Group announced substantial multi-million-dollar investments into its two founding flagship hotels - Mandarin Oriental, Hong Kong, and Mandarin Oriental, Bangkok. This dedication was also recognised with Amber at The Landmark Mandarin Oriental, Hong Kong, earning three coveted Michelin stars in March - a testament to the Group's relentless pursuit of exceptional culinary experiences.

Β 

One Causeway Bay - the Group's mixed-use commercial redevelopment in Hong Kong remains on budget and on track to be completed in the second half of the year. The Group's liquidity position remains robust, with US$462 million headroom in available committed debt facilities and US$178 million of cash reserves. Gearing was 3% of adjusted shareholders' funds, slightly higher than 2% at the end of last year.

Β 

Mandarin Oriental Hotel Group is the award-winning owner and operator of some of the world's most luxurious hotels, resorts and residences. Having grown from its Asian roots into a global brand, the Group now operates 43 hotels, 12 residences and 26 exceptional homes in 26 countries and territories, with each property reflecting the Group's oriental heritage, local culture and unique design. Mandarin Oriental has a strong pipeline of hotels and residences under development.

Β 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the equity shares (transition) category of the London Stock Exchange, with secondary listings in Bermuda and Singapore. The activities of the Group's hotels are managed from Hong Kong. Mandarin Oriental is a member of the Jardine Matheson group.

Β 

- end -

Β 

For further information, please contact:

Β 

Max Fleming (Director of Corporate Finance) (852) 2895 9171

Β 

Chris Orlikowski (Director of Global Communications) (44) 791 7280 210

William Brocklehurst (Brunswick Group Limited) (852) 5685 9881

Β 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DOCBELFFEELZBBB
Date   Source Headline
8th May 201912:32 pmRNSInterim Management Statement
2nd May 201910:20 amRNSDividend
29th Apr 201910:49 amRNSFirst Quarter 2019 Results of PT Hero
26th Apr 201910:35 amRNSJC&C 2019 First Quarter Financial Statements
24th Apr 201911:09 amRNSPT Astra 2019 First Quarter Financial Statements
18th Apr 201910:57 amRNSDividend
4th Apr 201910:11 amRNSAnnual Financial Report
29th Mar 20199:15 amRNSTotal Voting Rights
27th Mar 20199:12 amRNSCirc re. Scrip Dividend Scheme
26th Mar 20199:14 amRNSDirector/PDMR Shareholding
25th Mar 20199:12 amRNSBlock listing Interim Review
20th Mar 201910:53 amRNSDirector/PDMR Shareholding
7th Mar 20199:12 amRNSDirector/PDMR Shareholding
28th Feb 20199:25 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:23 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:19 amRNSFull Year 2018 Results of PT Hero
28th Feb 20199:18 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 Preliminary Announcement of Results
27th Feb 20199:50 amRNSJC&C 2018 Financial Statements
27th Feb 20199:41 amRNSPT Astra Intl TBK - 2018 FY Financial Statements
31st Jan 20199:07 amRNSTotal Voting Rights
30th Jan 20199:15 amRNSNotice of 2018 Final Results
24th Jan 201911:08 amRNSDirector/PDMR Shareholding
8th Jan 201910:18 amRNSDirector/PDMR Shareholding
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 201811:32 amRNSDirector Declaration
17th Dec 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
7th Dec 20189:08 amRNSDirectorate Change
30th Nov 20189:16 amRNSTotal Voting Rights
23rd Nov 20189:10 amRNSDF Completes Partnership with Robinsons in Phl
8th Nov 20189:20 amRNSInterim Management Statement
8th Nov 20189:17 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:10 amRNSInterim Management Statement
7th Nov 20189:21 amRNS2018 Third Quarter Financial Statements
31st Oct 20189:10 amRNSTotal Voting Rights
30th Oct 201810:02 amRNSNine Months 2018 Results of PT Hero
29th Oct 20187:00 amRNSPT Astra 2018 Third Quarter Financial Statements
24th Oct 201811:31 amRNSDirector/PDMR Shareholding
11th Oct 201811:52 amRNSDirector/PDMR Shareholding
10th Oct 201810:13 amRNSDirector/PDMR Shareholding
5th Oct 201810:35 amRNSAdditional Listing
2nd Oct 201811:04 amRNSForm 8.3 - Jardine Lloyd Thompson Group plc
2nd Oct 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.